106,513 Cigna Group $CI Shares Bought by Robeco Institutional Asset Management B.V.

Robeco Institutional Asset Management B.V. grew its position in shares of Cigna Group (NYSE:CI) by 57.2% during the third quarter, HoldingsChannel reports. The firm owned 292,602 shares of the health services provider’s stock after buying an additional 106,513 shares during the period. Robeco Institutional Asset Management B.V.’s holdings in Cigna Group were worth $79,538,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in the company. Assetmark Inc. lifted its stake in shares of Cigna Group by 10.0% in the first quarter. Assetmark Inc. now owns 65,662 shares of the health services provider’s stock worth $17,515,000 after acquiring an additional 5,963 shares in the last quarter. Mystic Asset Management Inc. purchased a new position in Cigna Group in the second quarter valued at about $2,808,000. KBC Group NV boosted its holdings in Cigna Group by 6.4% in the second quarter. KBC Group NV now owns 380,034 shares of the health services provider’s stock valued at $104,768,000 after purchasing an additional 22,978 shares during the last quarter. Nykredit A S acquired a new stake in Cigna Group during the 2nd quarter valued at approximately $15,300,000. Finally, Sanctuary Advisors LLC acquired a new stake in Cigna Group during the 2nd quarter valued at approximately $11,043,000. 86.99% of the stock is owned by institutional investors and hedge funds.

Cigna Group Stock Down 0.6%

NYSE:CI opened at $304.74 on Thursday. The company has a market capitalization of $80.53 billion, a price-to-earnings ratio of 12.61, a price-to-earnings-growth ratio of 1.03 and a beta of 0.29. Cigna Group has a one year low of $239.51 and a one year high of $311.34. The stock has a 50-day simple moving average of $280.49 and a 200 day simple moving average of $282.73. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76.

Cigna Group (NYSE:CI) last announced its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, beating the consensus estimate of $7.60 by $0.18. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%. The firm had revenue of $71.56 billion during the quarter, compared to analyst estimates of $70.14 billion. During the same period in the previous year, the company earned $7.20 earnings per share. Cigna Group’s quarterly revenue was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Sell-side analysts predict that Cigna Group will post 30.50 EPS for the current fiscal year.

Insider Activity at Cigna Group

In related news, insider Nicole S. Jones sold 19,436 shares of the company’s stock in a transaction that occurred on Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the sale, the insider directly owned 27,256 shares of the company’s stock, valued at approximately $7,530,015.12. This represents a 41.63% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Everett Neville sold 617 shares of the company’s stock in a transaction that occurred on Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total value of $175,258.85. Following the sale, the insider directly owned 5,053 shares in the company, valued at approximately $1,435,304.65. This represents a 10.88% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 22,730 shares of company stock valued at $6,293,359. Insiders own 0.60% of the company’s stock.

Analyst Upgrades and Downgrades

CI has been the topic of several analyst reports. Royal Bank Of Canada restated an “outperform” rating and set a $337.00 price objective on shares of Cigna Group in a report on Thursday, October 1st. UBS Group reiterated a “buy” rating on shares of Cigna Group in a research note on Thursday, October 1st. Jefferies Financial Group downgraded shares of Cigna Group from a “buy” rating to a “hold” rating and decreased their price target for the stock from $336.00 to $307.00 in a research report on Tuesday, August 4th. Wall Street Zen upgraded shares of Cigna Group from a “hold” rating to a “buy” rating in a research note on Saturday, September 26th. Finally, Raymond James Financial lowered shares of Cigna Group from a “strong-buy” rating to an “outperform” rating and dropped their price target for the stock from $350.00 to $320.00 in a research note on Monday, August 3rd. Fifteen research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company’s stock. According to MarketBeat, Cigna Group has a consensus rating of “Moderate Buy” and a consensus price target of $338.24.

Cigna Group Profile

The Cigna Group (NYSE: CI) is a global health services company that provides insurance coverage, health care benefits and related services. Its operations are primarily organized through Cigna Healthcare, which offers medical, pharmacy, dental, behavioral health and other benefit programs to employers, government organizations and individuals, primarily in the United States.

The company also operates Evernorth Health Services, a health services platform that includes pharmacy benefit management, specialty pharmacy, care management and health-care delivery capabilities.